Gladstone Commercial Corp. (0IVQ)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 11.90 |
|---|---|
| 52-week range | 9.60 – 13.18 |
| Return, 1 month / 3 months | −6.6% / −6.3% |
| Return, 1 year / 3 years | +15.5% / +26.1% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 24.2% |
| Worst drawdown (1 year) | -13.0% |
| Average daily value traded | 0.08M USD |
| Dividend yield | 10.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gladstone Commercial Corporation is a real estate investment trust that owns and acquires commercial properties, mainly industrial and office buildings, which it leases to small and medium-sized businesses under long-term net leases. Its tenants operate across many industries, and the trust collects rent from them rather than running the businesses itself. The company is based in McLean, Virginia, in the United States, and its properties are spread across several regions of the country.
The shares are listed on the London Exchange in UK under the code 0IVQ, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gladstone Commercial Corp. (0IVQ) trades on the London Exchange in UK. It last closed at USD 11.90 on 19 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,074 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.5% and over the last three months it fell 6.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.1% | ||
| From 52-week high | -8.7% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -6.3% | ||
| 6-month return | 0.6% | ||
| 12-month return, skipping the last month | 23.7% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.0% | ||
| Liquidity | 28 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.08M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 91 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 10.1% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −5.9% |
|---|---|
| 1 month | −6.6% |
| 3 months | −6.3% |
| 6 months | +0.6% |
| 1 year | +15.5% |
| 3 years | +26.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 12.75 / 11.91 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.38 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Sep 2026 | USD 0.1000 |
| 18 Aug 2026 | USD 0.1000 |
| 24 Jul 2026 | USD 0.1000 |
| 23 Jun 2026 | USD 0.1000 |
| 20 May 2026 | USD 0.1000 |
| 24 Apr 2026 | USD 0.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.